CDKL5: A TEP for Inflammation and Neuropsychiatry

CDKL5 harbours loss of function mutations causing a variant of #RettSyndrome, & may be a drug target for acute kidney injury. Our #CDKL5 Target Enabling Package (#TEP) shows structures (with inhibitors), in vitro assays, & functional analyses in C. elegans http://doi.org/10.5281/zenodo.5128460